
Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51
Author(s) -
Gibson William J.,
Gibson C. Michael,
Yee Megan K.,
Korjian Serge,
Daaboul Yazan,
Plotnikov Alexei N.,
Burton Paul,
Braunwald Eugene
Publication year - 2019
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.118.009451
Subject(s) - medicine , timi , rivaroxaban , acute coronary syndrome , aspirin , myocardial infarction , cardiology , clinical endpoint , coronary artery disease , thrombolysis , randomized controlled trial , warfarin , atrial fibrillation